MSF Demands Affordable Access to Key HIV Prevention Drug
Doctors Without Borders (MSF) is demanding a drastic price reduction for the long-acting HIV prevention drug lenacapavir, calling for generic production to hit a target of $40 per person per year as the International AIDS Conference opens in Rio de Janeiro, according to the medical humanitarian organization. Gilead Pricing Sparks Global Access Debate US pharmaceutical … Read more